Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Gene-based vaccination produces immune responses against PSMA
May 10th, 2006
According to recent research from the United States published in the journal Cancer Gene Therapy, gene-based vaccination produces immune responses against prostate-specific membrane antigen (PSMA). "Two plasmid DNA vaccines, encoding either products that are retained in the cytosol and degraded in the proteasome (tVacs; hPSMAt), or secreted proteins (sVacs; hPSMAs) were evaluated for stimulation of cytotoxic cell or antibody responses," wrote M. Mincheff and colleagues, George Washington University. "Immunization with both vectors led to generation of cell cytotoxicity providing granulocyte-macrophage colony-stimulating factor was administered...
Source: Vaccine Weekly (2006-05-10)
|
